Leiden, The Netherlands, 22 June 2012 - Prosensa, the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, has won the Emerging Star accolade at last night’s European Mediscience Aw [...]
Utrecht, The Netherlands, June 20, 2012 – Merus B.V., a biopharmaceutical company focused on multispecific human antibody therapeutics, announced today that it has been granted the first European patent covering its Ol [...]
Utrecht, The Netherlands, June 15, 2012 – Merus B.V., a biopharmaceutical company focused on multispecific human antibody therapeutics, announced today that Jason Avery has been appointed as Chief Business Officer.
[...]
-Patent will expand intellectual property protection for MYDICAR – a first in class drug under clinical evaluation for advanced heart failure -
SAN DIEGO, June 18, 2012 /PRNewswire/ -- Celladon Corporation, a biopha [...]
As of June 15, 2012, a comprehensive molecular diagnostic testing service is available for any hospital in Europe. The assay menu consists of Skyline’s AMLprofilerTM, and LabPMM’s LeukostratTM FLT3 and NPM1 Mutation [...]
Leuven (BELGIUM) – June 8, 2012 – TiGenix (NYSE Euronext: TIG) announced today that its innovative cartilage repair therapy ChondroCelect® has obtained national reimbursement in the Netherlands. The Dutch National H [...]
4-Antibody and Evotec launch a new high-content screening platform for early antibody functionality testing
Basel, Switzerland, & Hamburg, Germany, 9th May, 2012: 4-Antibody AG and Evotec AG (Frankfurt Stock Exchange: [...]
-MPM Capital and LSP Life Sciences Partners join existing Celladon investment syndicate-
-Total capital proceeds of recent investment round increased to $53 million-
SAN DIEGO, May 7, 2012 /PRNewswire/ --Celladon [...]
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA Leiden, the Netherlands, 25 April 2012 – OctoPlus N.V. (“OctoPlus” or the “Company”) (Euron [...]
Rotterdam, the Netherlands and Ghent, Belgium April 24, 2012 – arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody™ platfo [...]
Leiden, The Netherlands, 22 June 2012 - Prosensa, the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, has won the Emerging Star accolade at last night’s European Mediscience Aw [...]
Utrecht, The Netherlands, June 20, 2012 – Merus B.V., a biopharmaceutical company focused on multispecific human antibody therapeutics, announced today that it has been granted the first European patent covering its Ol [...]
Utrecht, The Netherlands, June 15, 2012 – Merus B.V., a biopharmaceutical company focused on multispecific human antibody therapeutics, announced today that Jason Avery has been appointed as Chief Business Officer.
[...]
-Patent will expand intellectual property protection for MYDICAR – a first in class drug under clinical evaluation for advanced heart failure -
SAN DIEGO, June 18, 2012 /PRNewswire/ -- Celladon Corporation, a biopha [...]
As of June 15, 2012, a comprehensive molecular diagnostic testing service is available for any hospital in Europe. The assay menu consists of Skyline’s AMLprofilerTM, and LabPMM’s LeukostratTM FLT3 and NPM1 Mutation [...]
Leuven (BELGIUM) – June 8, 2012 – TiGenix (NYSE Euronext: TIG) announced today that its innovative cartilage repair therapy ChondroCelect® has obtained national reimbursement in the Netherlands. The Dutch National H [...]
4-Antibody and Evotec launch a new high-content screening platform for early antibody functionality testing
Basel, Switzerland, & Hamburg, Germany, 9th May, 2012: 4-Antibody AG and Evotec AG (Frankfurt Stock Exchange: [...]
-MPM Capital and LSP Life Sciences Partners join existing Celladon investment syndicate-
-Total capital proceeds of recent investment round increased to $53 million-
SAN DIEGO, May 7, 2012 /PRNewswire/ --Celladon [...]
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA Leiden, the Netherlands, 25 April 2012 – OctoPlus N.V. (“OctoPlus” or the “Company”) (Euron [...]
Rotterdam, the Netherlands and Ghent, Belgium April 24, 2012 – arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody™ platfo [...]
Follow us
